(Q48273348)

10 February 2018

title

Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. (English)

1 reference

10 February 2018

5

A Mark Richards

1 reference

10 February 2018

Tim Yandle

6

object named as

Timothy G Yandle

1 reference

10 February 2018

author name string

Timothy M Sutton

1

1 reference

10 February 2018

Ralph A H Stewart

2

1 reference

10 February 2018

Ivor L Gerber

3

1 reference

10 February 2018

Teena M West

4

1 reference

10 February 2018

Andrew J Kerr

7

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 June 2003

1 reference

10 February 2018

Journal of the American College of Cardiology

published in

1 reference

10 February 2018

volume

41

1 reference

10 February 2018

issue

12

1 reference

10 February 2018

page(s)

2280-2287

1 reference

10 February 2018

Clinical practice. Evaluation and management of chronic mitral regurgitation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

The Mitral Regurgitation Index: an echocardiographic guide to severity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

How leaky is that mitral valve? Simplified Doppler methods to measure regurgitant orifice area

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Left ventricular function in chronic mitral regurgitation: preoperative and postoperative comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Dise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

The timing of surgery for severe mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

1 reference

7 January 2021

Natriuretic peptides--relevance in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Quantitative Doppler assessment of valvular regurgitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

The use of transformation when comparing two means

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Atrial Natriuretic Peptide and Brain Natriuretic Peptide Coexist in the Secretory Granules of Human Cardiac Myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Plasma brain natriuretic peptide in assessment of acute dyspnoea.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Plasma brain natriuretic peptide concentration: impact of age and gender

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900486-8

7 January 2021

10.1016/S0735-1097(03)00486-8

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

12821260

1 reference

10 February 2018